SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Deborah Majchel, Mary T. Korytkowski, Anticytotoxic T-Lymphocyte Antigen-4 Induced Autoimmune Hypophysitis: A Case Report and Literature Review, Case Reports in Endocrinology, 2015, 2015, 1

    CrossRef

  2. 2
    Robert Cheng, Adam Cooper, James Kench, Geoff Watson, William Bye, Catriona McNeil, Nicholas Shackel, Ipilimumab-induced toxicities and the gastroenterologist, Journal of Gastroenterology and Hepatology, 2015, 30, 4
  3. 3
    Rachel Gormley, Karolyn Wanat, Rosalie Elenitsas, Julia Giles, Suzanne McGettigan, Lynn Schuchter, Junko Takeshita, Ipilimumab-associated Sweet syndrome in a melanoma patient, Journal of the American Academy of Dermatology, 2014, 71, 5, e211

    CrossRef

  4. You have free access to this content4
    Jeffrey S. Weber, Reinhard Dummer, Veerle de Pril, Celeste Lebbé, F. Stephen Hodi, Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab, Cancer, 2013, 119, 9
  5. 5
    Ena Wang, Lorenzo Uccellini, Francesco M. Marincola, A genetic inference on cancer immune responsiveness, OncoImmunology, 2012, 1, 4, 520

    CrossRef

  6. You have free access to this content6
    Elisabeth Livingstone, Lisa Zimmer, Julia Vaubel, Dirk Schadendorf, Current advances and perspectives in the treatment of advanced melanoma, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2012, 10, 5
  7. 7
    Christine Koch, Sylvie Paetzold, Joerg Trojan, Enterocolitis in a Patient Being Treated With Ipilimumab for Metastatic Melanoma, Gastroenterology, 2012, 143, 2, 298

    CrossRef

  8. 8
    Grazia Graziani, Lucio Tentori, Pierluigi Navarra, Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer, Pharmacological Research, 2012, 65, 1, 9

    CrossRef

  9. You have free access to this content9
    Lisa Zimmer, Julia Vaubel, Elisabeth Livingstone, Dirk Schadendorf, Side effects of systemic oncological therapies in dermatology, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2012, 10, 7
  10. 10
    Shikhar Aggarwal, Arjan A. van de Loosdrecht, Canan Alhan, Gert J. Ossenkoppele, Theresia M. Westers, Hetty J. Bontkes, Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy, British Journal of Haematology, 2011, 153, 5
  11. 11
    Samantha Turnbull, Endocrine therapy, immunotherapy and targeted therapies,
  12. 12
    Teresa Alonso Gordoa, Javier Puente Vázquez, Eduardo Díaz-Rubio, Ipilimumab (Yervoy®),
  13. 13
    Mary Ann N. Johnson, April W. Armstrong, Treatment of Cutaneous Melanoma,